This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Sodium valproate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Sodium valproate or valproic acid (VPA) is an anti-seizure medication licensed for epilepsy and as a mood stabilizer for bipolar disorder.[1][2][3] Sodium valproate is sometimes used off-label for nerve pain.[3]

Theory[edit | edit source]

Evidence[edit | edit source]

No sodium valproate clinical trials have been done with ME/CFS patients.

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Sodium valproate cannot be taken during pregnancy and effective contraception must be used due to the high risk of harm to the baby.[4]

Carnitine levels may be lowered by sodium valproate, taking L-carnitine or Acetyl-L-carnitine supplements is advised against.[5]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Valproic acid: medicine used for bipolar disorder, epilepsy and migraine". National Health Service. September 27, 2018. Retrieved December 28, 2023.
  2. "Valproic Acid (Oral Route) Side Effects - Mayo Clinic". Mayo Clinic. Retrieved December 28, 2023.
  3. Jump up to: 3.0 3.1 Rahman, Masum; Awosika, Ayoola O.; Nguyen, Hoang (2023). Valproic Acid. Treasure Island (FL): StatPearls Publishing. PMID 32644538.
  4. "Sodium valproate medicines and risks in pregnancy". Epilepsy Action. Retrieved December 28, 2023.
  5. Dechéne, Lucy (2015). "Review of Nutritional Supplements Used for ME/CFS/FM". Massachusetts ME/CFS & FM Association. Retrieved December 28, 2023.